USMLE Road Map Pharmacology by Bertram G. Katzung, Anthony J. Trevor PDF


By Bertram G. Katzung, Anthony J. Trevor

ISBN-10: 0071445811

ISBN-13: 9780071445818

USMLE street Map: Pharmacology offers a concise and centred exam of the fundamental thoughts in pharmacology. via a streamlined and easy-to-follow hierarchical define structure, it courses scholars in the course of the most crucial attributes of every drug classification and reports the mechanisms, activities, and uncomfortable side effects of every drug prototype. the description is stronger with an in depth and unique representation application that visually conveys the fundamental details and promotes retention of the cloth. positive aspects similar to scientific correlations and medical difficulties also are incorporated.

Show description

Read Online or Download USMLE Road Map Pharmacology PDF

Similar pharmacology books

New PDF release: High-Yield Pharmacology (3rd Edition) (High-Yield Series)

Now in its 3rd version, High-Yield™ Pharmacology offers a succinct evaluation of pharmacology whereas clarifying tricky options. Need-to-know info is gifted in a transparent, concise define layout. extra gains comprise up to date drug references, a drug index, key issues in daring, and tables summarizing key proof.

Emilio Benfenati's In Silico Methods for Predicting Drug Toxicity PDF

This specific quantity explores in silico tools for pharmaceutical toxicity through combining the theoretical complicated learn with the sensible software of the instruments. starting with a bit protecting subtle types addressing the binding to receptors, pharmacokinetics and adsorption, metabolism, distribution, and excretion, the e-book maintains with chapters delving into versions for particular toxicological and ecotoxicological endpoints, in addition to vast perspectives of the most tasks and new views with the intention to in all likelihood increase our manner of modelling prescription drugs.

Additional resources for USMLE Road Map Pharmacology

Example text

However, there is also a little used, so-called Phase 0 stage of human testing in which greatly reduced, sub-therapeutic single doses of the potential drug are administered to a very few volunteers, 5–15, with the aim of studying the compound’s pharmacodynamics (how the drug works in the body) and/or pharmacokinetics (how the body processes the drug). Phase 0 studies are also known as human micro dosing studies. While Phase 0 studies are first-in-human studies, they are not designed to gain information on efficacy or safety.

The results of studies done under an IND are ultimately a part of the NDA for obtaining approval. There are exceptions to the requirement that agents not be used for treatment unless they have been proved to be safe and effective. Chief among these exceptions is the regulation allowing a so called “treatment IND” which allows an experimental drug which shows promise in clinical testing, to be used to treat serious or immediately life-threatening conditions before the final clinical 46 10 The FDA Approval Process and Drug Development work on the drug is conducted and the FDA review takes place.

FDA must have already authorized the claim; 2. S. government or a National Academy of Science scientific body must have issued a statement on the relationship; or 3. ” The third type of allowable claim, nutrient content claims, are very limited and may only be made based on FDA authorizing regulations. Nutrient content claims allow the label to state the level of a nutrient or dietary substance and use terms such as “free”, “high”, “low”, “more”, “reduced” and “lite”. As regards the safety of supplements, the company which manufactures or distributes the supplements is responsible for the agent’s safety and must have evidence to support that their claims are not misleading or false.

Download PDF sample

USMLE Road Map Pharmacology by Bertram G. Katzung, Anthony J. Trevor

by Kenneth

Rated 4.72 of 5 – based on 35 votes